Inhibition of cellular adhesion in human umbilical vein endothelial cells by NF-kappaB inhibitor DHMEQ under flow. 2005

Osamu Ohno, and Yutaka Shima, and Yasuo Ikeda, and Kumi Sakurai, and Kiyoaki Watanabe, and Yohko Kawai, and Kazuo Umezawa
Department of Applied Chemistry, Faculty of Science and Technology, Keio University, 3-14-1 Hiyoshi, Kohoku-ku, Yokohama 223-0061, Japan.

We previously designed and synthesized DHMEQ as an inhibitor of NF-kappaB. In the present study, we looked into the effect of DHMEQ on the cell adhesion in human umbilical vein endothelial cells (HUVEC) under flow. We used freshly prepared HUVEC and human mononuclear cells throughout the experiment. DHMEQ inhibited TNF-alpha-, IL-1beta-, and LPS-induced NF-kappaB activation in HUVEC. It also inhibited TNF-alpha-induced expression of intercellular adhesion molecule-1 (ICAM-1), vascular cell adhesion molecule-1 (VCAM-1), and E-selectin. DHMEQ also inhibited TNF-alpha-induced mononuclear cell-HUVEC adhesion. The effect of DHMEQ was more prominent when the cells were under shear stress. DHMEQ inhibited the adhesion between HUVEC and HT-29 colon cancer cells more clearly under the flow condition than under the static condition of the culture medium. These results suggest that DHMEQ, being a unique inhibitor of NF-kappaB, may be effective in suppressing atherosclerosis and metastasis by inhibiting the expression of adhesion molecules.

UI MeSH Term Description Entries
D007962 Leukocytes White blood cells. These include granular leukocytes (BASOPHILS; EOSINOPHILS; and NEUTROPHILS) as well as non-granular leukocytes (LYMPHOCYTES and MONOCYTES). Blood Cells, White,Blood Corpuscles, White,White Blood Cells,White Blood Corpuscles,Blood Cell, White,Blood Corpuscle, White,Corpuscle, White Blood,Corpuscles, White Blood,Leukocyte,White Blood Cell,White Blood Corpuscle
D002448 Cell Adhesion Adherence of cells to surfaces or to other cells. Adhesion, Cell,Adhesions, Cell,Cell Adhesions
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D003512 Cyclohexanones Cyclohexane ring substituted by one or more ketones in any position.
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001549 Benzamides BENZOIC ACID amides.
D001696 Biomechanical Phenomena The properties, processes, and behavior of biological systems under the action of mechanical forces. Biomechanics,Kinematics,Biomechanic Phenomena,Mechanobiological Phenomena,Biomechanic,Biomechanic Phenomenas,Phenomena, Biomechanic,Phenomena, Biomechanical,Phenomena, Mechanobiological,Phenomenas, Biomechanic
D014409 Tumor Necrosis Factor-alpha Serum glycoprotein produced by activated MACROPHAGES and other mammalian MONONUCLEAR LEUKOCYTES. It has necrotizing activity against tumor cell lines and increases ability to reject tumor transplants. Also known as TNF-alpha, it is only 30% homologous to TNF-beta (LYMPHOTOXIN), but they share TNF RECEPTORS. Cachectin,TNF-alpha,Tumor Necrosis Factor Ligand Superfamily Member 2,Cachectin-Tumor Necrosis Factor,TNF Superfamily, Member 2,TNFalpha,Tumor Necrosis Factor,Cachectin Tumor Necrosis Factor,Tumor Necrosis Factor alpha
D014471 Umbilical Veins Venous vessels in the umbilical cord. They carry oxygenated, nutrient-rich blood from the mother to the FETUS via the PLACENTA. In humans, there is normally one umbilical vein. Umbilical Vein,Vein, Umbilical,Veins, Umbilical
D015153 Blotting, Western Identification of proteins or peptides that have been electrophoretically separated by blot transferring from the electrophoresis gel to strips of nitrocellulose paper, followed by labeling with antibody probes. Immunoblotting, Western,Western Blotting,Western Immunoblotting,Blot, Western,Immunoblot, Western,Western Blot,Western Immunoblot,Blots, Western,Blottings, Western,Immunoblots, Western,Immunoblottings, Western,Western Blots,Western Blottings,Western Immunoblots,Western Immunoblottings

Related Publications

Osamu Ohno, and Yutaka Shima, and Yasuo Ikeda, and Kumi Sakurai, and Kiyoaki Watanabe, and Yohko Kawai, and Kazuo Umezawa
January 2010, Oncology research,
Osamu Ohno, and Yutaka Shima, and Yasuo Ikeda, and Kumi Sakurai, and Kiyoaki Watanabe, and Yohko Kawai, and Kazuo Umezawa
May 2010, Microbes and infection,
Osamu Ohno, and Yutaka Shima, and Yasuo Ikeda, and Kumi Sakurai, and Kiyoaki Watanabe, and Yohko Kawai, and Kazuo Umezawa
April 2001, Journal of ethnopharmacology,
Osamu Ohno, and Yutaka Shima, and Yasuo Ikeda, and Kumi Sakurai, and Kiyoaki Watanabe, and Yohko Kawai, and Kazuo Umezawa
July 2005, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie,
Osamu Ohno, and Yutaka Shima, and Yasuo Ikeda, and Kumi Sakurai, and Kiyoaki Watanabe, and Yohko Kawai, and Kazuo Umezawa
May 2006, Experimental biology and medicine (Maywood, N.J.),
Osamu Ohno, and Yutaka Shima, and Yasuo Ikeda, and Kumi Sakurai, and Kiyoaki Watanabe, and Yohko Kawai, and Kazuo Umezawa
November 2007, Leukemia research,
Osamu Ohno, and Yutaka Shima, and Yasuo Ikeda, and Kumi Sakurai, and Kiyoaki Watanabe, and Yohko Kawai, and Kazuo Umezawa
August 2010, Acta pharmacologica Sinica,
Osamu Ohno, and Yutaka Shima, and Yasuo Ikeda, and Kumi Sakurai, and Kiyoaki Watanabe, and Yohko Kawai, and Kazuo Umezawa
October 2009, American journal of physiology. Cell physiology,
Osamu Ohno, and Yutaka Shima, and Yasuo Ikeda, and Kumi Sakurai, and Kiyoaki Watanabe, and Yohko Kawai, and Kazuo Umezawa
October 2009, American journal of physiology. Cell physiology,
Osamu Ohno, and Yutaka Shima, and Yasuo Ikeda, and Kumi Sakurai, and Kiyoaki Watanabe, and Yohko Kawai, and Kazuo Umezawa
September 2021, Cells,
Copied contents to your clipboard!